As the largest private equity fund in Asia, the position change of Hillhouse Capital has always been concerned by all parties.

Just now, Hillhouse announced its position in U.S. stocks at the end of the second quarter of 2020 at the Securities and Exchange Commission (SEC).

Data displayHillhouse Capital holds shares in 74 companies in US stocks, with biomedical and Internet technology as the main distribution areas, with a market capitalization of $10.94 billion (76.034 billion yuan). Chinese-listed stocks still occupy a strong position.

By the end of the second quarter of 2020, US stocks held by Hillhouse Capital accounted for eight positions in the top 10 heavy stocks.The top five heavy stocks areBeiGene, Ltd. 、ZOOM, iQIYI, Inc., BABA and PinduoduoThe market capitalization of the holdings is $1.739 billion, $1.083 billion, $1.031 billion, $848 million and $847 million, respectively.

Data showHillhouse Capital focuses on the Internet, medicine and consumer sectors, and currently manages assets.six hundred and fiftyIt is one of the largest and best-performing private equity fund managers in Asia.

13 new pharmaceutical companies

In the Hillhouse position portfolio, biotechnology, medical and pharmaceutical companies have always been the focus.New entrants in this quarterseventeenAmong the enterprises, there arethirteenAll of them are enterprises in the field of biopharmaceutical.The number of biomedical companies in 73 positions has reached 42, with a market capitalization of more than $3 billion. Among them, BeiGene, Ltd., which Hillhouse has invested eight times in a row, is among the top five heavy stocks in several quarters, and the market value of its holdings has increased by nearly 54 per cent compared with the previous quarter.

Data show that at present, Hillhouse has invested in more than 160 enterprises in biomedicine, medical devices, medical services, pharmaceutical retail and other fields, including more than 100 Chinese enterprises. The total investment is more than 120 billion yuan, and the total market value of the investment enterprise is more than 2.5 trillion yuan.

China-listed stocks occupy an important position.

According to 13F data, among the top 10 heavy stocks in Hillhouse, Chinese stocks occupy eight seats. IQIYI, Inc., BeiGene, Ltd., BABA, Pinduoduo, TAL Education Group, JD.com, Bilibili Inc. and Taibang Bio have a combined market capitalization of more than 5.54 billion US dollars, accounting for 50.7% of the total market value.

Among them, in the second quarter, Pinduoduo rose more than 138%, Bilibili Inc. rose more than 97%, BeiGene, Ltd., JD.com and other stocks all rose more than 48%.

Hillhouse still values the tremendous changes that Chinese enterprises have brought to the country and the world economy and society, and the strategy of "investing heavily in China" has also been profoundly demonstrated.

Overweight enterprise service investment

It is worth noting that in the latest 13F document, Hillhouse adds "hard core technology", which occupies an important position in Hillhouse's position portfolio.

According to 13F data, in the second quarter, Sound Network, GDS Holdings Limited and other hard technology companies are Hillhouse Capital's new shareholding list.

Take Sound Network as an example. As a real-time interactive cloud service provider, Sound Network focuses on mobile HD real-time call cloud service solutions, while GDS Holdings Limited is China's leading high-performance data center developer and operator. Further, this is also in line with the corporate service track that Hillhouse has long been optimistic about.